SynBioBeta Speaker
Sarah Tao
Head of Search & Eval, Tech Platforms
Sanofi
YEAR
25
May 2025, SynBioBeta
Speaker
Sarah Tao, PhD, is the Head of Search & Evaluation, Technology Platforms within Global Business Development at Sanofi. In this role, she is responsible for identifying and evaluating external technologies that align with Sanofi’s strategies for its therapeutic modalities. Dr. Tao joined Sanofi in 2017 as Technology Lead for Biologics Research with successive roles in Research before shifting to Business Development in 2021. Prior to Sanofi, Dr. Tao was a Senior Manager of New Technologies at CooperVision leading external research programs, and was also a Senior Member of the Technical Staff in the MEMS Design Group at Draper Laboratory. She received her Ph. D. in Biomedical Engineering from Boston University with a research focus on MEMS-based devices for oral drug delivery.
SynBioBeta 2025 - Session Speaker
Innovation Meets Industry: How Startups Can Collaborate with Big Pharma
For startups in the BioPharma space, partnering with big pharma can be the key to scaling innovation and driving real-world impact. This session will bring together leaders from major pharmaceutical companies and successful startups to explore how to bridge the gap between groundbreaking ideas and industry execution. Learn about the key factors pharma companies look for in potential partners, best practices for collaboration" with "Innovation Meets Industry: How Startups Can Collaborate with Big Pharma"
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
2026
Event Updates